Return to Golf After Orthopaedic Surgery

Sponsor
Hospital for Special Surgery, New York (Other)
Overall Status
Recruiting
CT.gov ID
NCT05675618
Collaborator
Royal Infirmary of Edinburgh (Other)
432
2
34.7
216
6.2

Study Details

Study Description

Brief Summary

The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty. The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Patients who are active golfers undergoing joint replacement will be identified from outpatient clinics and pre-assessment clinics and given information about the study at least two weeks prior to surgery. Participants in this study must have a desire to return to golf after surgery. Previous studies have only been able to report the return to golf after arthroplasty retrospectively; the prospective nature of this study will allow for a greater understanding of this process.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    432 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Golfing After Orthopaedic Surgery: a Longitudinal Follow-up (GOLF) Project
    Actual Study Start Date :
    Jan 9, 2023
    Anticipated Primary Completion Date :
    Jan 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of return to golf following joint arthroplasty [Up to 1 year postoperatively]

      Patients will be asked if they have returned to golf (putting, chipping, 9 holes, 18 holes, etc) following joint arthroplasty.

    Secondary Outcome Measures

    1. Golf awareness after arthroplasty score [Up to 1 year postoperatively]

      This questionnaire assesses awareness of the joint replacement while playing golf and engaging in specific golf activities. A higher score represents more awareness, whereas a lower score represents less awareness.

    2. Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR) [Up to 1 year postoperatively]

      The HOOS JR measures overall hip health on a scale of 0-100, where 0 represents total hip disability and 100 represents perfect hip health. This will be administered specifically to patients undergoing hip arthroplasty.

    3. Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR) [Up to 1 year postoperatively]

      The KOOS JR measures overall knee health on a scale of 0-100, where 0 represents total knee disability and 100 represents perfect knee health. This will be administered specifically to patients who undergo knee arthroplasty.

    4. American Shoulder and Elbow Surgeons Shoulder Score (ASES) [Up to 1 year postoperatively]

      The ASES measures shoulder function on a scale of 0-100, where 0 represents worse function and 100 represents best function. This will be administered specifically to patients who undergo shoulder arthroplasty.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Age 18+ years

    • A self-reported golfer

    • Able to consent to treatment

    • Indicated for one of the following surgical procedures: total hip arthroplasty, hip resurfacing, revision hip arthroplasty, total knee arthroplasty, unicompartmental knee arthroplasty, revision knee arthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, shoulder resurfacing arthroplasty, revision shoulder arthroplasty

    Exclusion Criteria:
    • Inability to complete follow-up questionnaires

    • Declining operative management

    • No desire to return to golf postoperatively

    • Medical problem that affects the patient's ability to play golf (e.g., angina, shortness of breath, etc.)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital for Special Surgery New York New York United States 10021
    2 Royal Infirmary of Edinburgh Edinburgh United Kingdom

    Sponsors and Collaborators

    • Hospital for Special Surgery, New York
    • Royal Infirmary of Edinburgh

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hospital for Special Surgery, New York
    ClinicalTrials.gov Identifier:
    NCT05675618
    Other Study ID Numbers:
    • 2021-0437
    First Posted:
    Jan 9, 2023
    Last Update Posted:
    Jan 13, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hospital for Special Surgery, New York
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 13, 2023